project id: TCGA-LIHC; case submitter id: TCGA-MR-A8JO; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.16; rna integrity number: 7.0; age at index: 34; days to birth: -12669; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1979; age at diagnosis: 12669; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 330.0; icd 10 code: C22.0; last known disease status: not reported; morphology: 8171/3; primary diagnosis: Hepatocellular carcinoma, fibrolamellar; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Liver; synchronous malignancy: No; tissue or organ of origin: Liver; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 184; days to sample procurement: 0; initial weight: 350.0; portion submitter id: TCGA-MR-A8JO-01A-12; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0;